KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Correction: A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.

Int J Gynecol Cancer 33(10) 1672

PMID37783482
PMCID-
DOI10.1136/ijgc-2023-004812corr1
发表日期2023-10-02
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。